• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低HEAR评分用于识别无需肌钙蛋白检测、发生重大不良心脏事件风险极低的急诊科胸痛患者的外部验证。

External validation of a low HEAR score to identify emergency department chest pain patients at very low risk of major adverse cardiac events without troponin testing.

作者信息

O'Rielly Connor M, Andruchow James E, McRae Andrew D

机构信息

Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 3E34, Calgary, AB, T2N 4Z6, Canada.

出版信息

CJEM. 2022 Jan;24(1):68-74. doi: 10.1007/s43678-021-00159-y. Epub 2021 Jul 17.

DOI:10.1007/s43678-021-00159-y
PMID:34273102
Abstract

BACKGROUND

The history, ECG, age, risk factor (HEAR) score has been proposed to identify patients at sufficiently low risk of acute coronary syndrome that they may not require troponin testing. The objective of this study was to externally validate a low HEAR score to identify emergency department (ED) patients with chest pain at very low risk of 30-day major adverse cardiac events (MACE).

METHODS

This was a secondary analysis of a prospective cohort of patients requiring troponin testing to rule out myocardial infarction (MI) in a large urban ED. HEAR scores were calculated in two cohorts: (1) patients with no known history of coronary artery disease (CAD); and (2) all eligible patients. The proportion of patients classified as very low risk, sensitivity, specificity, predictive values and likelihood ratios at each cut-off were quantified for index acute myocardial infarction (AMI) and 30-day MACE at HEAR = 0 and HEAR ≤ 1 thresholds.

RESULTS

Of the 1150 patients included in this study, 820 (71.3%) had no history of CAD, 97 (8.4%) had index AMI and 123 (10.7%) had 30-day MACE. In patients with no prior history of CAD, HEAR ≤ 1 identified 202 (24.6%) of patients as very low risk for 30-day MACE with 98.4% (95% CI 91.6-99.9%) sensitivity. Among all patients, HEAR ≤ 1 identified 202 (17.6%) patients as very low risk for 30-day MACE with 99.2% (95% CI 95.6-99.9%) sensitivity.

CONCLUSIONS

A HEAR score ≤ 1 can identify more than 17% of all patients as very low risk for index AMI and 30-day MACE and unlikely to benefit from troponin testing. Broad implementation of this strategy could lead to significant resource savings.

摘要

背景

有人提出采用病史、心电图、年龄、危险因素(HEAR)评分来识别急性冠状动脉综合征风险足够低、可能无需进行肌钙蛋白检测的患者。本研究的目的是对外验证低HEAR评分,以识别胸痛急诊患者30天主要不良心脏事件(MACE)风险极低的患者。

方法

这是对一个前瞻性队列的二次分析,该队列患者来自一个大型城市急诊科,需要进行肌钙蛋白检测以排除心肌梗死(MI)。在两个队列中计算HEAR评分:(1)无已知冠状动脉疾病(CAD)病史的患者;(2)所有符合条件的患者。在HEAR = 0和HEAR≤1阈值下,对各切点处被归类为极低风险的患者比例、敏感性、特异性、预测值和似然比进行量化,用于索引急性心肌梗死(AMI)和30天MACE。

结果

本研究纳入的1150例患者中,820例(71.3%)无CAD病史,97例(8.4%)发生索引AMI,123例(10.7%)发生30天MACE。在无CAD病史的患者中,HEAR≤1将202例(24.6%)患者识别为30天MACE极低风险患者,敏感性为98.4%(95%CI 91.6 - 99.9%)。在所有患者中,HEAR≤1将202例(17.6%)患者识别为30天MACE极低风险患者,敏感性为99.2%(95%CI 95.6 - 99.9%)。

结论

HEAR评分≤1可将超过17%的所有患者识别为索引AMI和30天MACE极低风险患者,不太可能从肌钙蛋白检测中获益。广泛实施该策略可显著节省资源。

相似文献

1
External validation of a low HEAR score to identify emergency department chest pain patients at very low risk of major adverse cardiac events without troponin testing.低HEAR评分用于识别无需肌钙蛋白检测、发生重大不良心脏事件风险极低的急诊科胸痛患者的外部验证。
CJEM. 2022 Jan;24(1):68-74. doi: 10.1007/s43678-021-00159-y. Epub 2021 Jul 17.
2
Prehospital Modified HEART Score Predictive of 30-Day Adverse Cardiac Events.院前改良HEART评分对30天不良心脏事件的预测作用
Prehosp Disaster Med. 2018 Feb;33(1):58-62. doi: 10.1017/S1049023X17007154. Epub 2018 Jan 10.
3
Evaluation of HEAR score to rule-out major adverse cardiac events without troponin test in patients presenting to the emergency department with chest pain.运用 HEAR 评分系统,在急诊科胸痛就诊患者中,无需进行肌钙蛋白检测即可排除主要不良心脏事件。
Eur J Emerg Med. 2021 Aug 1;28(4):292-298. doi: 10.1097/MEJ.0000000000000791.
4
Identifying low-risk chest pain in the emergency department without troponin testing: a validation study of the HE-MACS and HEAR risk scores.在急诊室不进行肌钙蛋白检测识别低危胸痛:HE-MACS 和 HEAR 风险评分的验证研究。
Emerg Med J. 2022 Jul;39(7):515-518. doi: 10.1136/emermed-2021-211669. Epub 2021 Nov 9.
5
Efficacy of HEAR and HEART score to rule out major adverse cardiac events in patients presenting to the emergency department with chest pain: study protocol of the eCARE stepped-wedge randomised control trial.HEAR 和 HEART 评分对急诊科胸痛患者排除主要不良心脏事件的疗效:eCARE 逐步随机对照试验研究方案。
BMJ Open. 2022 Dec 6;12(12):e066953. doi: 10.1136/bmjopen-2022-066953.
6
Monocyte chemoattractant protein-1 is not predictive of cardiac events in patients with non-low-risk chest pain.单核细胞趋化蛋白-1 不能预测非低危胸痛患者的心脏事件。
Emerg Med J. 2022 Nov;39(11):853-858. doi: 10.1136/emermed-2021-211266. Epub 2021 Dec 21.
7
Identification of very low-risk acute chest pain patients without troponin testing.不进行肌钙蛋白检测识别极低危急性胸痛患者。
Emerg Med J. 2020 Nov;37(11):690-695. doi: 10.1136/emermed-2020-209698. Epub 2020 Aug 4.
8
Prehospital Comparison of the HEAR and HE-MACS Scores for 30-Day Adverse Cardiac Events.院前HEAR和HE-MACS评分对30天不良心脏事件的比较。
Prehosp Emerg Care. 2024;28(1):23-29. doi: 10.1080/10903127.2022.2142343. Epub 2022 Nov 29.
9
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.高敏肌钙蛋白 I 在 2 小时诊断策略中的验证,以评估急诊科疑似急性冠状动脉综合征患者 30 天结局。
J Am Coll Cardiol. 2013 Oct 1;62(14):1242-1249. doi: 10.1016/j.jacc.2013.02.078. Epub 2013 Apr 10.
10
Undetectable Concentrations of a Food and Drug Administration-approved High-sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival.在急诊科就诊时,使用美国食品药品监督管理局批准的高敏心肌肌钙蛋白T检测法检测不到的浓度,以排除急性心肌梗死。
Acad Emerg Med. 2017 Oct;24(10):1267-1277. doi: 10.1111/acem.13229. Epub 2017 Aug 11.

引用本文的文献

1
Implementation of a High-sensitivity Troponin Assay for Adult Patients Who Present to the Emergency Department With Chest Pain: The Role of Clinical Decision Support.为因胸痛就诊于急诊科的成年患者实施高敏肌钙蛋白检测:临床决策支持的作用
CJC Open. 2024 Sep 29;6(12):1491-1500. doi: 10.1016/j.cjco.2024.09.010. eCollection 2024 Dec.
2
Assessment and Application of the Hear Score in Remote Emergency Medicine Outposts in Bosnia and Herzegovina.Hear评分在波斯尼亚和黑塞哥维那远程急救医学前哨站的评估与应用
Medicina (Kaunas). 2024 Apr 19;60(4):657. doi: 10.3390/medicina60040657.
3
Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events.

本文引用的文献

1
Validation study of the modified HEART and HEAR scores in patients with chest pain who visit the emergency department.改良HEART和HEAR评分在胸痛急诊患者中的验证研究。
Acute Med Surg. 2020 Nov 7;7(1):e591. doi: 10.1002/ams2.591. eCollection 2020 Jan-Dec.
2
Identifying Patients with Low Risk of Acute Coronary Syndrome Without Troponin Testing: Validation of the HEAR Score.不进行肌钙蛋白检测识别低风险急性冠状动脉综合征患者:HEAR 评分的验证。
Am J Med. 2021 Apr;134(4):499-506.e2. doi: 10.1016/j.amjmed.2020.09.021. Epub 2020 Oct 27.
3
Emergency department use during COVID-19 as described by syndromic surveillance.
主要不良心血管事件的HEAR评分与HEART评分比较
Cureus. 2023 Oct 9;15(10):e46721. doi: 10.7759/cureus.46721. eCollection 2023 Oct.
4
HEAR SCORE: A Proposal to Use Only Anamnestic and EKG Data to Evaluate Patients with Very Low Risk Chest Pain.HEAR评分:一项仅使用既往病史和心电图数据评估极低风险胸痛患者的提议。
Open Access Emerg Med. 2023 Jan 19;15:29-36. doi: 10.2147/OAEM.S391929. eCollection 2023.
5
Can ED chest pain patients with intermediate HEART scores be managed as outpatients?ED 胸痛且 HEART 评分处于中间范围的患者能否作为门诊患者进行管理?
CJEM. 2022 Nov;24(7):770-779. doi: 10.1007/s43678-022-00355-4. Epub 2022 Sep 21.
基于症状监测描述的 COVID-19 期间急诊科的使用情况。
Emerg Med J. 2020 Oct;37(10):600-604. doi: 10.1136/emermed-2020-209980. Epub 2020 Sep 18.
4
Prospective comparative evaluation of the European Society of Cardiology (ESC) 1-hour and a 2-hour rapid diagnostic algorithm for myocardial infarction using high-sensitivity troponin-T.采用高敏肌钙蛋白 T 对欧洲心脏病学会(ESC)1 小时和 2 小时快速诊断算法在心肌梗死中的应用进行前瞻性对比评估。
CJEM. 2020 Sep;22(5):712-720. doi: 10.1017/cem.2020.349.
5
Low High-Sensitivity Troponin Thresholds Identify Low-Risk Patients With Chest Pain Unlikely to Benefit From Further Risk Stratification.低高敏肌钙蛋白阈值可识别出胸痛低风险患者,这类患者不太可能从进一步的风险分层中获益。
CJC Open. 2019 Aug 27;1(6):289-296. doi: 10.1016/j.cjco.2019.08.002. eCollection 2019 Nov.
6
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association.急诊科胸痛患者的诊断和风险分层:重点关注急性冠状动脉综合征。急性心血管护理协会的立场文件。
Eur Heart J Acute Cardiovasc Care. 2020 Feb;9(1):76-89. doi: 10.1177/2048872619885346. Epub 2020 Jan 20.
7
HEART Score Risk Stratification of Low-Risk Chest Pain Patients in the Emergency Department: A Systematic Review and Meta-Analysis.急诊低危胸痛患者 HEART 评分风险分层:系统评价和荟萃分析。
Ann Emerg Med. 2019 Aug;74(2):187-203. doi: 10.1016/j.annemergmed.2018.12.010. Epub 2019 Feb 2.
8
Safely Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge.安全识别急诊科急性胸痛患者以实现早期出院。
Circulation. 2018 Nov 27;138(22):2456-2468. doi: 10.1161/CIRCULATIONAHA.118.036528.
9
Emergency Department Volume and Outcomes for Patients After Chest Pain Assessment.胸痛评估后患者的急诊科就诊量及治疗结果
Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004683. doi: 10.1161/CIRCOUTCOMES.118.004683.
10
The HEART Pathway Randomized Controlled Trial One-year Outcomes.HEART 路径随机对照试验一年期结果。
Acad Emerg Med. 2019 Jan;26(1):41-50. doi: 10.1111/acem.13504. Epub 2018 Jul 19.